Paul David Bach is COO at Genesis Healthcare, Inc. (GEN). They have made 9 open-market trades across 1 company since 2017, most recently 2021-05-15.
CIK 0001693042
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GEN | 952,089 | $29.4M |
Shares reported on the most recent Form 4, priced at the 2021-05-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEN | SELL | 2020-06-03 | 2020-06-04 | $0.96 | $7K | -5.0% | -6.9% | +12.6% |
| GEN | SELL | 2020-05-20 | 2020-05-22 | $0.62 | $13K | +2.9% | +1.0% | +10.5% |
| GEN | SELL | 2019-06-12 | 2019-06-14 | $1.17 | $15K | +5.2% | +15.2% | +23.8% |
| GEN | SELL | 2019-06-03 | 2019-06-05 | $1.16 | $10K | +3.5% | +31.0% | +20.4% |
| GEN | SELL | 2019-05-20 | 2019-05-22 | $1.20 | $14K | -5.7% | +4.1% | +18.7% |
| GEN | SELL | 2018-06-12 | 2018-06-13 | $2.28 | $13K | -4.2% | +1.4% | -6.4% |
| GEN | SELL | 2018-06-05 | 2018-06-07 | $2.19 | $22K | -1.3% | +1.4% | -6.5% |
| GEN | SELL | 2017-06-14 | 2017-06-15 | $1.73 | $11K | -0.8% | +7.7% | +16.8% |
| GEN | SELL | 2017-06-07 | 2017-06-09 | $1.61 | $4K | -1.7% | -1.5% | +3.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.